CA
IBB icon

CoreCap Advisors’s iShares Biotechnology ETF IBB Stock Holding History

CoreCap Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$479K Buy
2,277
+403
+22% +$80.9K 0.01% 546
2026
Q2 		$356K Buy
1,874
+254
+16% +$43.7K 0.01% 660
2026
Q1 		$274K Sell
1,620
-1,027
-39% -$176K 0.01% 693
2025
Q4 		$447K Buy
2,647
+1,448
+121% +$235K 0.02% 536
2025
Q3 		$173K Sell
1,199
-112
-9% -$15.3K 0.01% 848
2025
Q2 		$166K Buy
1,311
+65
+5% +$7.98K 0.01% 802
2025
Q1 		$159K Buy
1,246
+67
+6% +$9.09K 0.01% 734
2024
Q4 		$156K Sell
1,179
-40
-3% -$5.62K 0.01% 775
2024
Q3 		$177K Buy
+1,219
New +$176K 0.01% 730
2024
Q2 		– Sell
-1,313
Closed -$180K – 2047
2024
Q1 		$180K Buy
+1,313
New +$179K 0.01% 659
2022
Q4 		$220K Buy
+1,679
New +$217K 0.02% 515
2022
Q3 		– Sell
-1,917
Closed -$226K – 1222
2022
Q2 		$226K Buy
1,917
+3
+0.2% +$356 0.02% 486
2022
Q1 		$250K Sell
1,914
-158
-8% -$20.6K 0.02% 452
2021
Q4 		$316K Buy
+2,072
New +$321K 0.02% 435

Other funds holding IBB

AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $480M AUM 43.68% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
KIG
Kessler Investment Group Columbus, Indiana $207M AUM 43.85% 1-Year Est. Return
DI
Decision Investments San Diego, California $110M AUM 52.83% 1-Year Est. Return

CoreCap Advisors's IBB Position: Q3 2026 in Review

CoreCap Advisors increased its iShares Biotechnology ETF (IBB) stake by 22% in Q3 2026, buying an estimated $80.9K and bringing the position to 2,277 shares worth $479K. The position accounts for 0.01% of the portfolio, ranked #546.

CoreCap Advisors first reported a position in IBB in Q4 2021 and has held it in 14 quarters since. 37 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • CoreCap Advisors held 2,277 shares of iShares Biotechnology ETF worth $479K as of Q3 2026.
  • CoreCap Advisors bought 403 iShares Biotechnology ETF shares in Q3 2026, an estimated $80.9K.
  • iShares Biotechnology ETF made up 0.01% of CoreCap Advisors's portfolio in Q3 2026, its #546 holding.
  • CoreCap Advisors first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 14 quarters since.
  • 37 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.